China Traditional Chinese Medicine Holdings Stock Forecast for 2023 - 2025 - 2030
Updated on 04/20/2024
China Traditional Chinese Medicine Holdings Stock Forecast and Price Target
The average price target for China Traditional Chinese Medicine Holdings's stock lately set by several renowned analysts is HK$4.31, which would result in a potential downside of approximately -0.23% if it reaches this mark by December 31, 2024. This estimation is based on a high estimate of HK$5.08 and a low estimate of HK$3.91. If you are looking to invest in the stock, it's important to research and compare different companies.
-0.23% Downside
China Traditional Chinese Medicine Holdings Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, China Traditional Chinese Medicine Holdings's Price has fallen from HK$4.30 to HK$0.00 – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach HK$4.82 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 600085 Stock Forecast | Beijing Tongrentang | Outperform |
16
|
¥42.20 | Buy/Sell | ¥61.18 | 27.96% |
| 600518 Stock Forecast | Kangmei Pharmaceutical | - |
6
|
¥1.91 | Buy/Sell | ¥25.97 | -100.00% |
| 300026 Stock Forecast | Tianjin Chase Sun Pharmaceutic... | Buy |
14
|
¥3.69 | Buy/Sell | ¥7.66 | 8.40% |
| 300147 Stock Forecast | Xiangxue Pharmaceutical | - |
10
|
¥4.67 | Buy/Sell | ¥49.01 | -100.00% |
| 600222 Stock Forecast | Henan Taloph Pharmaceutical St... | - |
15
|
¥4.79 | Buy/Sell | ¥24.97 | -100.00% |
China Traditional Chinese Medicine Holdings Revenue Forecast for 2023 - 2025 - 2030
In the last two years, China Traditional Chinese Medicine Holdings's Revenue has fallen from HK$14.81B to HK$14.30B – a 3.39% decrease. In the next year, analysts believe that Revenue will reach HK$23.48B – an increase of 64.11%. For the next seven years, the forecast is for Revenue to grow by 81.62%.
.jpg)
China Traditional Chinese Medicine Holdings Dividend per Share Forecast for 2023 - 2025 - 2030
China Traditional Chinese Medicine Holdings's Dividend per Share has decreased In the last year, from HK$0.12 to HK$0.05 – a 58.33% drop. In the next year, analysts believe that Dividend per Share will reach HK$0.13 – an increase of 160.00%. For the next seven years, experts predict that China Traditional Chinese Medicine Holdings's Dividend per Share will grow at a rate of 320.68%.
China Traditional Chinese Medicine Holdings EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, China Traditional Chinese Medicine Holdings's EBITDA has gone down from HK$3.11B to HK$2.22B – a 28.85% drop. For the next year, analysts predict that EBITDA will reach HK$2.86B – an increase of 28.87%. Over the next seven years, experts believe that China Traditional Chinese Medicine Holdings's EBITDA will grow at a rate of 42.82%.
China Traditional Chinese Medicine Holdings EBIT Forecast for 2023 - 2025 - 2030
In the last two years, China Traditional Chinese Medicine Holdings's EBIT has fallen from HK$2.47B to HK$1.17B – a 52.50% decrease. In the next year, analysts predict that EBIT will jump to HK$1.95B – up 66.26% from the current level. Looking ahead to seven years, experts forecast that EBIT will grow by 80.05%.
China Traditional Chinese Medicine Holdings EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, China Traditional Chinese Medicine Holdings's EPS has fallen from HK$0.33 to HK$0.00 – a 100.00% decrease. In the next year, analysts believe that EPS will reach HK$0.37 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
Site Navigation
.jpg)